Sympathetic overactivity in the development of eyelid retraction in a patient with euthyroid Graves' disease evaluated by accommodation

被引:8
|
作者
Hamada, N
Okamoto, Y
Yoshida, H
Tsumura, K
Nakamura, Y
Noh, JY
机构
[1] Sumire Hosp, Joto Ku, Osaka 5360001, Japan
[2] Osaka City Univ, Sch Med, Dept Internal Med 2, Abeno Ku, Osaka 5450051, Japan
[3] NTT, Osaka Cent Hlth Adm Ctr, Kita Ku, Osaka 5300005, Japan
[4] Ito Hosp, Shibuya Ku, Tokyo 1508308, Japan
关键词
eyelid retraction; euthyroid Graves' disease; accommodation; sympathetic overactivity; guanethidine;
D O I
10.1507/endocrj.47.623
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is known that measurement of accommodation is useful to evaluate the sympathetic activity of intraocular muscles. To find if sympathetic overactivity is involved in eyelid retraction in euthyroid Graves' disease, we measured accommodation in two patients with this disease, whose serum concentrations of free T3, free T4 and TSH were within reference ranges. Accommodation was measured with a computer-assisted infrared optometer with an iriscoder, and the results were expressed as the change in the eye's refractive power (in diopters) in response to the movement of a target beam. In patient 1, the accommodation amplitude was low, indicating sympathetic overactivity. This amplitude rose to near the reference range when timolol maleate drops were used, and the eyelid retraction disappeared when guanethidine drops were given. During the use of guanethidine drops, accommodation remained normal. In patient 2, who had normal accommodation, eyelid retraction did not change with guanethidine administration, but improved with intravenous methylprednisolone pulse therapy. These two cases suggested that even in euthyroid Graves' disease, eyelid retraction is caused by sympathetic overactivity, and pulse therapy with methylprednisolone may be effective for eyelid retraction when guanethidine drops are not effective.
引用
收藏
页码:623 / 628
页数:6
相关论文
共 32 条
  • [1] Sympathetic overactivity of intraocular muscles evaluated by accommodation in patients with hyperthyroidism
    Noh, JY
    Nakamura, Y
    Ito, K
    Inoue, Y
    Abe, Y
    Hamada, N
    THYROID, 1996, 6 (04) : 289 - 293
  • [2] EYELID RETRACTION IN GRAVES EYE DISEASE
    FRUEH, BR
    OPHTHALMOLOGY, 1989, 96 (10) : 1574 - 1575
  • [3] UPPER EYELID RETRACTION AND GRAVES-DISEASE
    GROVE, AS
    OPHTHALMOLOGY, 1981, 88 (06) : 499 - 506
  • [4] EYELID RETRACTION IN GRAVES EYE DISEASE - REPLY
    SMALL, RG
    OPHTHALMOLOGY, 1989, 96 (10) : 1575 - 1575
  • [5] Graves Disease: Correcting upper eyelid retraction
    Frueh, BR
    OPHTHALMOLOGY, 1996, 103 (11) : 1713 - 1713
  • [6] Pathological Findings of the Thyroid Tissue in a Patient with Euthyroid Graves' Disease
    Suzuki, Nami
    Yoshihara, Ai
    Noh, Jaeduk Yoshimura
    Kozaki, Ai
    Inoue, Toshu
    Sugino, Kiminori
    Ito, Koichi
    INTERNAL MEDICINE, 2015, 54 (22) : 2881 - 2884
  • [7] Thyroid-stimulating antibody in a patient with euthyroid Graves' disease
    Kubo, T
    Toki, J
    Kado, Y
    Kurihara, M
    Moriwake, T
    Kanzaki, S
    Seino, Y
    ENDOCRINE JOURNAL, 2000, 47 (02) : 197 - 201
  • [8] Features of untreated Graves' disease patients with bilateral upper eyelid retraction
    Kozaki, Ai
    Inoue, Rishu
    Ito, Gaku
    Mizuno, Kahori
    Inoue, Toshu
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [9] Full thickness eyelid transsection (blepharotomy) for upper eyelid lengthening in lid retraction associated with Graves' disease
    Hintschich, C
    Haritoglou, C
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2005, 89 (04) : 413 - 416
  • [10] Euthyroid dysprealbuminemic hyperthyroxinemia in a patient with Graves' disease: A unique combination.
    Cameron, SJ
    Hagedorn, JC
    Sokoll, IJ
    Caturegli, P
    Ladenson, PW
    CLINICAL CHEMISTRY, 2004, 50 (06) : A103 - A103